期刊文献+

反义寡核苷酸抑制人恶性黑素瘤A375细胞乙酰肝素酶mRNA及其蛋白的表达 被引量:3

Inhibitory effects of antisense oligodeoxynucleotide on the expression of heparinase mRNA and protein in human malignant melanoma cell line A375
原文传递
导出
摘要 目的 研究乙酰肝素酶反义寡核苷酸(ASODN)对人恶性黑素瘤A375细胞乙酰肝素酶mRNA及其蛋白表达的影响。方法 分空白组、无关序列(N-ODN)组和反义(ASODN)组。以脂质体包埋后分别转染人恶性黑素瘤细胞株A375,采用原位杂交、免疫组化法检测乙酰肝素酶mRNA及其蛋白表达的变化。结果 转染24h后,ASODN组A375细胞乙酰肝素酶mRNA表达较对照组、N-ODN组均显著下调(P均〈0.01);转染48h后,与对照组、N-ODN组相比,ASODN组A375细胞的乙酰肝素酶蛋白水平均显著下降(P均〈0.01)。结论 乙酰肝素酶ASODN可下调A375细胞乙酰肝素酶mRNA及其蛋白的表达。 Objective To study the effects of heparinase antisense oligodeoxynucleotide ( ASODN ) on the expression of heparinase mRNA and protein in human malignant melanoma cell line A375. Methods Heparinase ASODN and its controlled nonsense oligodeoxynucleotide (N-ODN) were designed and synthesized. A375 cells were divided into three groups: ASODN group, transfected with 30 μmol/L of heparinase ASODN and lipofectin; N-ODN group, transfected with 30 μmol/L of heparinase N-ODN and lipofectin; blank control group. Heparinase mRNA and protein were detected by in situ hybridization and immunohistochemistry, respectively. Results At 24 h after the transfection, the expression of heparinase mRNA was significantly lower in the ASODN group than that in the N-ODN group and control group ( 1.250 ±0.500 vs 4.000 ± 0.817, 1.250 ±0.500 vs 4.250 ±0.500, both P〈 0.01 ). The expression of heparinase protein was also significantly decreased in the ASODN group than that in the control and N-ODN group at 48 h after transfection ( 5.000 ±0.817 vs 1.500± 0.577, 4.500 ± 0.577 vs 1.500 ±0.577, both P 〈 0.01 ). Conclusion Heparinase ASODN could down-regulate the expression of heparinase mRNA and protein in A375 cells.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2007年第3期170-172,共3页 Chinese Journal of Dermatology
关键词 黑色素瘤 肝素裂合酶 寡核苷酸类 反义 Melanoma Heparin lyase Oligonucleotides, antisense
  • 相关文献

参考文献4

二级参考文献13

  • 1Ikeguchi M,Hirooka Y,Kaibara N.Heparanase gene expression and its correlation with spontaneous apoptosis in heparanase of cirrhotic liver and carcinoma.Eur J Cancer,2003, 39(1): 86-90
  • 2Bernfield M,Gotte M,Zako M.Functions of cell surface heparan sulfate proteoglycans.Annu Rev Biochem,1999,68: 729-777
  • 3Vlodavsky I,Goldshmidt O,Friedmann Y,et al.Mammalian heparanase: involvement in cancer metastasis,angiogenesis and normal development.Semin Cancer Biol,2002,12(2): 121
  • 4Baker E,Crawford J,Hulett MD,et al.Human HPA endoglycosidase heparanase.Map position 4q21.3.Chromosome Res,1999,7(4): 319
  • 5Fairbanks MB,Mildner AM,Leone JW,et al.Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer.J Biol Chem,1999,274(42): 29587-29590
  • 6Takaoka M,Naomoto Y,Ohkawa T,et al.Heparanase expression correlates with invasion and poor prognosis in gastric cancers.Lab Invest,2003,83(5): 613- 622
  • 7Kuniyasu H,Chihara Y,Kubozoe T,et al.Coexpression of CD44v3 and heparanase is correlated with metastasis of humancolon cancer.Int J Mol Med,2002,10(3): 3332-3337
  • 8Uno F,Fujiwara T,Takata Y,et al.Antisense mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.Cancer Res,2001,61(21): 7855-7860
  • 9Hulett MD,Freeman C,Hamdorf BJ,et al.Coloning of mammalian heparanase an important enzyme in tumor invasion and metastasis.Nat Med,1999,5(7): 803-809
  • 10Vlodavsky I,Elkin M,Pappo O,et al.Mammalian heparanase as mediator of tumor metastasis and angiogenesis.Isr Med Assoc J,2000,2(Suppl): 37-45

共引文献22

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部